Literature DB >> 16239304

Isolation and characterization of a transcriptional cofactor and its novel isoform that bind the deoxyribonucleic acid-binding domain of peroxisome proliferator-activated receptor-gamma.

Takuya Tomaru1, Teturou Satoh, Satoshi Yoshino, Takahiro Ishizuka, Koshi Hashimoto, Tsuyoshi Monden, Masanobu Yamada, Masatomo Mori.   

Abstract

Using the DNA-binding domain (DBD) and hinge region of human peroxisome proliferator-activated receptor (PPAR)-gamma as bait in yeast two-hybrid screen, we isolated partial cDNA identical with that of the C terminal of KIAA1769. KIAA1769 encodes a 2080-amino acid protein (molecular mass, 231 kDa) that was recently identified to interact with PPARalpha and termed PPARalpha-interacting cofactor 285 (here referred to as PPARgamma-DBD-interacting protein 1 (PDIP1)-alpha). PDIP1 mRNA was expressed in 3T3-L1 adipocytes and THP-1 macrophages. We also identified the expression of the N terminal extended form of PDIP1alpha (referred to as PDIP1beta) consisting of 2649 amino acids (295 kDa) in human cultured cell lines by RT-PCR, and 5' rapid amplification of cDNA ends. Ribonuclease protection assay revealed that PDIP1beta mRNA was expressed more abundantly than PDIP1alpha mRNA. The C-terminal region of PDIP1 directly binds DBD of PPARgamma, and multiple LXXLL motifs in PDIP1 were not required for the interaction. PDIP1alpha and -beta similarly enhanced PPARgamma-mediated transactivation in transfection assays and short interfering RNA targeting PDIP1 mRNA significantly reduced transactivation by PPARgamma. No potent intrinsic activation domain was identified in either PDIP1 isoforms in mammalian one-hybrid assays, and mutation of all LXXLL motifs did not affect enhancement of PPARgamma-mediated transactivation. PDIP1alpha and -beta similarly augmented transactivation by PPARalpha, PPARdelta, thyroid hormone receptor (TR)-alpha1, TRbeta1, and retinoid X receptor-alpha. PDIP1alpha also enhanced estrogen receptoralpha- and androgen receptor-mediated transactivation, whereas PDIP1beta did not. PDIP1alpha showed receptor-specific synergism with activation function-2-interacting coactivators in PPARgamma- and TRbeta1-mediated transactivation. Together, PDIP1 might function as a transcriptional cofactor for a broad range of nuclear receptors, possibly in collaboration with specific activation function-2 interacting coactivators.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16239304     DOI: 10.1210/en.2005-0450

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Systematic Investigation of Multi-TLR Sensing Identifies Regulators of Sustained Gene Activation in Macrophages.

Authors:  Bin Lin; Bhaskar Dutta; Iain D C Fraser
Journal:  Cell Syst       Date:  2017-07-26       Impact factor: 10.304

2.  THRAP3 interacts with HELZ2 and plays a novel role in adipocyte differentiation.

Authors:  Akiko Katano-Toki; Tetsurou Satoh; Takuya Tomaru; Satoshi Yoshino; Takahiro Ishizuka; Sumiyasu Ishii; Atsushi Ozawa; Nobuyuki Shibusawa; Takafumi Tsuchiya; Tsugumichi Saito; Hiroyuki Shimizu; Koshi Hashimoto; Shuichi Okada; Masanobu Yamada; Masatomo Mori
Journal:  Mol Endocrinol       Date:  2013-03-22

3.  Coactivators in PPAR-Regulated Gene Expression.

Authors:  Navin Viswakarma; Yuzhi Jia; Liang Bai; Aurore Vluggens; Jayme Borensztajn; Jianming Xu; Janardan K Reddy
Journal:  PPAR Res       Date:  2010-08-05       Impact factor: 4.964

4.  Tat-binding protein-1 (TBP-1), an ATPase of 19S regulatory particles of the 26S proteasome, enhances androgen receptor function in cooperation with TBP-1-interacting protein/Hop2.

Authors:  Tetsurou Satoh; Takahiro Ishizuka; Takuya Tomaru; Satoshi Yoshino; Yasuyo Nakajima; Koshi Hashimoto; Nobuyuki Shibusawa; Tsuyoshi Monden; Masanobu Yamada; Masatomo Mori
Journal:  Endocrinology       Date:  2009-03-26       Impact factor: 4.736

5.  A genetic screen identifies interferon-α effector genes required to suppress hepatitis C virus replication.

Authors:  Dahlene N Fusco; Cynthia Brisac; Sinu P John; Yi-Wen Huang; Christopher R Chin; Tiao Xie; Hong Zhao; Nikolaus Jilg; Leiliang Zhang; Stephane Chevaliez; Daniel Wambua; Wenyu Lin; Lee Peng; Raymond T Chung; Abraham L Brass
Journal:  Gastroenterology       Date:  2013-02-24       Impact factor: 22.682

6.  Genetics of gene expression in primary immune cells identifies cell type-specific master regulators and roles of HLA alleles.

Authors:  Benjamin P Fairfax; Seiko Makino; Jayachandran Radhakrishnan; Katharine Plant; Stephen Leslie; Alexander Dilthey; Peter Ellis; Cordelia Langford; Fredrik O Vannberg; Julian C Knight
Journal:  Nat Genet       Date:  2012-03-25       Impact factor: 38.330

Review 7.  Modulation of the transcriptional activity of peroxisome proliferator-activated receptor gamma by protein-protein interactions and post-translational modifications.

Authors:  Tae-Hyun Kim; Mi-Young Kim; Seong-Ho Jo; Joo-Man Park; Yong-Ho Ahn
Journal:  Yonsei Med J       Date:  2013-05-01       Impact factor: 2.759

8.  Molecular Mechanisms and Genome-Wide Aspects of PPAR Subtype Specific Transactivation.

Authors:  Anne Bugge; Susanne Mandrup
Journal:  PPAR Res       Date:  2010-08-31       Impact factor: 4.964

9.  Non-DNA binding, dominant-negative, human PPARgamma mutations cause lipodystrophic insulin resistance.

Authors:  Maura Agostini; Erik Schoenmakers; Catherine Mitchell; Istvan Szatmari; David Savage; Aaron Smith; Odelia Rajanayagam; Robert Semple; Jian'an Luan; Louise Bath; Anthony Zalin; Mourad Labib; Sudhesh Kumar; Helen Simpson; Dirk Blom; David Marais; John Schwabe; Inês Barroso; Richard Trembath; Nicholas Wareham; Laszlo Nagy; Mark Gurnell; Stephen O'Rahilly; Krishna Chatterjee
Journal:  Cell Metab       Date:  2006-10       Impact factor: 27.287

10.  DNA methylation patterns in naïve CD4+ T cells identify epigenetic susceptibility loci for malar rash and discoid rash in systemic lupus erythematosus.

Authors:  Paul Renauer; Patrick Coit; Matlock A Jeffries; Joan T Merrill; W Joseph McCune; Kathleen Maksimowicz-McKinnon; Amr H Sawalha
Journal:  Lupus Sci Med       Date:  2015-09-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.